The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they really work? Zoë Beaty looks at how the health landscape is rapidly changing to ...
Jan 8 (Reuters) - EliLilly's (LLY.N), opens new tab obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, broadening access to the ...
He now oversees EliLilly’s pipeline of incretin medications, including its blockbuster weight-loss drug Zepbound. Now, recent studies and clinical trials have found that these drugs also have ...
Some results have been hidden because they may be inaccessible to you